Niraj Vasisht
Board Member
Inhibitor Therapeutics, Inc. (INTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Niraj Vasisht
Niraj Vasisht is recorded as Board Member at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed September 18, 2026 that Niraj Vasisht was appointed Director, effective September 15, 2026.
“Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman were each elected to serve on the Board of Directors (the "Board") for a one-year term that expires at the 2027 Annual Meeting of Stockholders, or until their earlier death, resignation or removal and their successors are elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibitor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis E. O'Donnell CEO, Board Member
- Francis E. O'Donnell, Jr. CEO, Chairman
- Francis E. O'Donnell, Jr., M.D. CEO, Chairman
- James A. McNulty CFO
- James A. McNulty, CPA CFO
- Michael Jerman Board Member
- Michael Jerman, CPA. Board Member
- Michelle Yanez Board Member
- Michelle Yanez, MBA Board Member
- Niraj Vasisht, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.